Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism APOE agonists(Apolipoprotein E agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization Anji Pharmaceuticals, Inc.Startup |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypercholesterolemia | Phase 2 | - | Anji Pharmaceuticals, Inc.Startup | - |
Hyperlipidemia Type IIa | Phase 1 | AU | 26 May 2014 | |
Hyperlipoproteinemia Type II | Phase 1 | AU | 01 Mar 2014 |
Phase 1/2 | 52 | (AEM-28) | clpvvxnytt(xoizthmzmd) = uljohlxeec cvynerqdpj (sazdxorvwx, chhsuteriz - speyuyhvhm) View more | - | 29 Dec 2015 | ||
(Normal Saline) | clpvvxnytt(xoizthmzmd) = zcsfzqgvya cvynerqdpj (sazdxorvwx, xtzwxwlyeo - ofabgtirjx) View more |